Testing effectiveness (Phase 2)Ended earlyNCT03318523
What this trial is testing
Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease
Who this might be right for
Parkinson's Disease
Biogen 357